The Challenger Ltd (ASX: CGF) share price is in focus today as the company holds a market update on APRA's proposed capital standards, highlighting a stronger post-stress capital position and opportunities for strategic growth under the revised requirements.
Image source: Getty Images
What did Challenger report?
- Regulatory capital base of $4.5 billion as at 30 June 2025, unchanged under both current and proposed standards
- Prescribed Capital Amount (PCA) expected to reduce from $2.8 billion to $2.6 billion under new guidelines
- Pro forma PCA ratio increases from 1.60x to 1.77x, boosting resilience to market shocks
- Potential for ~$0.3 billion in excess Common Equity Tier 1 (CET1) capital and ~$0.1 billion in excess AT1/T2 capital if the target PCA ratio remains at 1.60x
- Greater investment in fixed income assets planned to support growth in annuity products
What else do investors need to know?
Challenger's update outlines how APRA's proposed, principles-based capital standards may deliver more stable, spread-based earnings and lower capital intensity for Challenger Life. The changes are designed to improve life insurers' competitiveness while maintaining financial resilience and aligning with international peers.
The company says its business model is ready to support long-term growth, with a continued focus on customer outcomes, retirement innovation, and industry partnerships. No immediate changes to the asset portfolio are planned, but further strategic assessments and scenario modelling will inform next steps.
What did Challenger management say?
Nick Hamilton, Managing Director & Chief Executive Officer said:
Our capital position is significantly more resilient to market shocks under the proposed standards, positioning us strongly for future growth opportunities.
What's next for Challenger?
Challenger will respond to APRA's capital standards consultation and undertake further detailed strategic assessments, including an actuarial review and capital management updates. The company also plans to review its investment strategy and integrate the new framework into its business planning and reporting guidance for FY27 and beyond.
The board will continue to review its target capital range, operational readiness, and implications for future product offerings as more detail around the final APRA standards becomes available.
Challenger share price snapshot
Challenger shares have soared 52% over the past 12 months, running well ahead of the S&P/ASX 200 Index (ASX: XJO) which has risen 8% over the same period.
